Press Release

01.03.2012

AIGO results on CEA-IgM presented at 18° FISMAD congress

Results deriving for the multicenter prospective AIGO study from 132 patients with CRC and 109 controls on CEA-IgM have been presented at the 18° FISMAD congress, Naples, Italy, March 28-31, 2012. Aim of the study, was to evaluate the diagnostic performance of CEA-IgM in a cohort of patients enrolled prospectively in a real clinical setting. In comparison to FOBT and serum CEA, study results encourage the use of CEA-IgM in patients with early cancer.